Results 281 to 290 of about 158,434 (296)

Trends in GPCR drug discovery: new agents, targets and indications

Nature Reviews Drug Discovery, 2017
Alexander S Hauser, Misty M Attwood, Mathias Rask-Andersen   +2 more
exaly  

Predictive biomarkers: a paradigm shift towards personalized cancer medicine

Nature Reviews Clinical Oncology, 2011
Nicholas B La Thangue, David J Kerr
exaly  

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Lancet, The, 2016
Russell E Ware, Banu Aygun, Alex George
exaly  

Doppler frequency shift

2014
openaire   +1 more source

Periodontitis: a polymicrobial disruption of host homeostasis

Nature Reviews Microbiology, 2010
Richard P Darveau
exaly  

Accelerating Drops and Doppler Shift

The Physics Teacher, 2002
openaire   +1 more source

The immune contexture in cancer prognosis and treatment

Nature Reviews Clinical Oncology, 2017
Wolf H Fridman, Laurence Zitvogel, Catherine Sautes-fridman   +2 more
exaly  

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

Nature Reviews Drug Discovery, 2004
Ma-Li Wong, Julio Licinio
exaly  

Doppler shifted de Broglie wave

American Journal of Physics, 1978
openaire   +1 more source

Metabolic targets for cancer therapy

Nature Reviews Drug Discovery, 2013
Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer   +2 more
exaly